바이오포토닉스 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트와 예측(2024-2032년)

Growth Factors of biophotonics Market

The global biophotonics market is expanding rapidly as technological innovation accelerates across medical diagnostics, life sciences, and agriculture. The market was valued at USD 62.60 billion in 2024, is projected to increase to USD 66.15 billion in 2025, and is expected to reach USD 121.98 billion by 2032, reflecting a steady CAGR of 9.1% during the forecast period. Biophotonics, an advanced interdisciplinary field combining photonics with biology, continues to reshape health monitoring, disease diagnostics, and scientific research. The technology encompasses imaging systems, lasers, fiber optics, and spectrometers that enable non-invasive diagnostics, high-resolution imaging, and sensitive detection across diverse industries.

The market's expansion is supported by rising healthcare spending and increasing demand for safe, real-time, and non-invasive diagnostic devices. Biophotonics has gained significant importance in early disease detection, particularly in oncology, neurology, cardiology, and cellular analysis. Its ability to detect biological changes at microscopic levels has positioned it as one of the most critical technologies in modern healthcare. Although the COVID-19 pandemic temporarily slowed operations due to infrastructure limitations, post-pandemic recovery triggered strong demand for handheld monitoring devices and rapid sensors, improving market stability.

Market Trends

One of the most prominent trends shaping the biophotonics market is the integration of Artificial Intelligence (AI) and Machine Learning (ML) into imaging and sensing systems. AI enhances the accuracy of biological measurements and accelerates disease detection by analyzing large datasets. With the growing adoption of miniature diagnostic sensors and connected medical devices, AI-enabled biophotonic tools provide faster, more precise results for clinicians and researchers. These advancements are expanding the potential of biophotonics in early cancer detection, personalized medicine, and point-of-care diagnostics.

Growth Drivers

Continuous technological advancements in microscopes, imaging devices, and spectroscopy systems remain the strongest drivers of market growth. Rising demand for non-invasive monitoring across personal and clinical healthcare sectors is fueling adoption. In January 2024, Carl Zeiss AG introduced new super-resolution microscopes-Lattice SIM 3 and Lattice SIM 5-which use structured illumination microscopy (SIM) to surpass the limits of traditional light microscopy. Such innovations highlight the industry's shift toward precision tools capable of identifying microscopic abnormalities in real time.

Another key driver is the increasing application of biophotonics in agriculture and food safety. Fiber optics and advanced spectrometers support pathogen detection, photosynthesis monitoring, and agri-tech analytics, making biophotonics essential beyond healthcare.

Market Restraints

High initial investment requirements for manufacturing and R&D remain a significant barrier, especially for small and emerging companies. Biophotonic devices require precision engineering, regulatory approvals, and stringent ergonomic standards, which increase production complexity. Compliance with global medical regulations further extends development timelines. Additionally, industry restructuring-such as Hamamatsu Photonics' 2024 sale of its subsidiary NKT Photonics-reflects ongoing pressure to streamline operations in a competitive environment.

Segmentation Insights

By Product

The laser segment holds the dominant share due to its extensive use in cancer treatment, dermatology, ophthalmology, and light-based therapies. Imaging systems are expected to grow at the highest rate as demand rises for high-resolution medical imaging and early disease detection. Meanwhile, fiber optics and spectrometers are gaining traction in both healthcare and agriculture, enabling rapid pathogen exposure detection and precision crop analytics.

By Application

Biological sensing & process remains the largest application segment, supported by heavy investment in life sciences research. Live cell imaging and optical sensing & detection continue to expand in pharmaceutical manufacturing and medical diagnostics. Emerging applications such as photosynthesis evaluation further highlight the role of biophotonics in crop science and agricultural innovation.

Regional Insights

The Asia Pacific region led the global market in 2024 with a value of USD 25.78 billion, boosted by expansive healthcare demand and strong life science research activity across China, India, Japan, Malaysia, and South Korea. North America is positioned for high growth due to its concentration of leading biophotonics companies and strong adoption of advanced medical imaging technologies. Europe also maintains steady progress, fueled by strict medical standards and rising investment in neurology, oncology, and biomedical imaging research. The Middle East & Africa and South America are exhibiting substantial growth as governments increase funding for crop science, healthcare analytics, and indigenous medical technologies.

Conclusion

With the market projected to reach USD 121.98 billion by 2032, biophotonics will continue transforming global healthcare and scientific research. Advancements in AI, imaging, sensing, and agricultural analytics will drive long-term adoption, making biophotonics a cornerstone of next-generation diagnostics and biotechnology innovation.

Segmentation By Products

• Imaging Systems
• Lasers
• Fiber Optics
• Others (Spectrometer, etc.)

By Application

• Biological sensing & process
• Live Cell Imaging
• Optical sensing & detection
• Photosynthesis evaluation
• Others (intracellular cAMP, scanner, etc.)

By Region

• North America (By Product, By Application, and By Country)
  • U.S. (By Application)
  • Canada (By Application)
  • Mexico (By Application)
• Europe (By Product, By Application, and By Country)
  • U.K. (By Application)
  • Germany (By Application)
  • France (By Application)
  • Italy (By Application)
  • Spain (By Application)
  • Russia (By Application)
  • Rest of Europe
• Asia Pacific (By Product, By Application, and By Country)
  • China (By Application)
  • India (By Application)
  • Japan (By Application)
  • South Korea (By Application)
  • ASEAN (By Application)
  • Rest of Asia Pacific
• Middle East & Africa (By Product, By Application, and By Country)
  • GCC (By Application)
  • South Africa (By Application)
  • Rest of Middle East & Africa (By Application)
• South America (By Product, By Application, and By Country)
  • Brazil (By Application)
  • Argentina (By Application)
  • Rest of South America

Table of Content

1. Introduction

• 1.1. Definition, By Segment
• 1.2. Research Methodology/Approach
• 1.3. Data Sources

2. Executive Summary

3. Market Dynamics

• 3.1. Macro and Micro Economic Indicators
• 3.2. Drivers, Restraints, Opportunities and Trends
• 3.3. Impact of Generative AI

4. Competition Landscape

• 4.1. Business Strategies Adopted by Key Players
• 4.2. Consolidated SWOT Analysis of Key Players
• 4.3. Global Biophotonics Key Players Market Share/Ranking, 2024

5. Global Biophotonics Market Size Estimates and Forecasts, By Segments, 2019-2032

• 5.1. Key Findings
• 5.2. By Product (USD)
  • 5.2.1. Imaging Systems
  • 5.2.2. Lasers
  • 5.2.3. Fiber Optics
  • 5.2.4. Others (Spectrometer, etc.)
• 5.3. By Application (USD)
  • 5.3.1. Biological sensing & process
  • 5.3.2. Live Cell Imaging
  • 5.3.3. Optical sensing & detection
  • 5.3.4. Photosynthesis evaluation
  • 5.3.5. Others (intracellular cAMP, scanner, etc.)
• 5.4. By Region (USD)
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Middle East & Africa
  • 5.4.5. South America

6. North America Biophotonics Market Size Estimates and Forecasts, By Segments, 2019-2032

• 6.1. Key Findings
• 6.2. By Product (USD)
  • 6.2.1. Imaging Systems
  • 6.2.2. Lasers
  • 6.2.3. Fiber Optics
  • 6.2.4. Others (Spectrometer, etc.)
• 6.3. By Application (USD)
  • 6.3.1. Biological sensing & process
  • 6.3.2. Live Cell Imaging
  • 6.3.3. Optical sensing & detection
  • 6.3.4. Photosynthesis evaluation
  • 6.3.5. Others (intracellular cAMP, scanner, etc.)
• 6.4. By Country (USD)
  • 6.4.1. United States
    • 6.4.1.1. By Application
  • 6.4.2. Canada
    • 6.4.2.1. By Application
  • 6.4.3. Mexico
    • 6.4.3.1. By Application

7. South America Biophotonics Market Size Estimates and Forecasts, By Segments, 2019-2032

• 7.1. Key Findings
• 7.2. By Product (USD)
  • 7.2.1. Imaging Systems
  • 7.2.2. Lasers
  • 7.2.3. Fiber Optics
  • 7.2.4. Others (Spectrometer, etc.)
• 7.3. By Application (USD)
  • 7.3.1. Biological sensing & process
  • 7.3.2. Live Cell Imaging
  • 7.3.3. Optical sensing & detection
  • 7.3.4. Photosynthesis evaluation
  • 7.3.5. Others (intracellular cAMP, scanner, etc.)
• 7.4. By Country (USD)
  • 7.4.1. Brazil
    • 7.4.1.1. By Application
  • 7.4.2. Argentina
    • 7.4.2.1. By Application
  • 7.4.3. Rest of South America

8. Europe Biophotonics Market Size Estimates and Forecasts, By Segments, 2019-2032

• 8.1. Key Findings
• 8.2. By Product (USD)
  • 8.2.1. Imaging Systems
  • 8.2.2. Lasers
  • 8.2.3. Fiber Optics
  • 8.2.4. Others (Spectrometer, etc.)
• 8.3. By Application (USD)
  • 8.3.1. Biological sensing & process
  • 8.3.2. Live Cell Imaging
  • 8.3.3. Optical sensing & detection
  • 8.3.4. Photosynthesis evaluation
  • 8.3.5. Others (intracellular cAMP, scanner, etc.)
• 8.4. By Country (USD)
  • 8.4.1. United Kingdom
    • 8.4.1.1. By Application
  • 8.4.2. Germany
    • 8.4.2.1. By Application
  • 8.4.3. France
    • 8.4.3.1. By Application
  • 8.4.4. Italy
    • 8.4.4.1. By Application
  • 8.4.5. Spain
    • 8.4.5.1. By Application
  • 8.4.6. Russia
    • 8.4.6.1. By Application
  • 8.4.7. Rest of Europe

9. Middle East & Africa Biophotonics Market Size Estimates and Forecasts, By Segments, 2019-2032

• 9.1. Key Findings
• 9.2. By Product (USD)
  • 9.2.1. Imaging Systems
  • 9.2.2. Lasers
  • 9.2.3. Fiber Optics
  • 9.2.4. Others (Spectrometer, etc.)
• 9.3. By Application (USD)
  • 9.3.1. Biological sensing & process
  • 9.3.2. Live Cell Imaging
  • 9.3.3. Optical sensing & detection
  • 9.3.4. Photosynthesis evaluation
  • 9.3.5. Others (intracellular cAMP, scanner, etc.)
• 9.4. By Country (USD)
  • 9.4.1. GCC
    • 9.4.1.1. By Application
  • 9.4.2. South Africa
    • 9.4.2.1. By Application
  • 9.4.3. Rest of MEA

10. Asia Pacific Biophotonics Market Size Estimates and Forecasts, By Segments, 2019-2032

• 10.1. Key Findings
• 10.2. By Product (USD)
  • 10.2.1. Imaging Systems
  • 10.2.2. Lasers
  • 10.2.3. Fiber Optics
  • 10.2.4. Others (Spectrometer, etc.)
• 10.3. By Application (USD)
  • 10.3.1. Biological sensing & process
  • 10.3.2. Live Cell Imaging
  • 10.3.3. Optical sensing & detection
  • 10.3.4. Photosynthesis evaluation
  • 10.3.5. Others (intracellular cAMP, scanner, etc.)
• 10.4. By Country (USD)
  • 10.4.1. China
    • 10.4.1.1. By Application
  • 10.4.2. India
    • 10.4.2.1. By Application
  • 10.4.3. Japan
    • 10.4.3.1. By Application
  • 10.4.4. South Korea
    • 10.4.4.1. By Application
  • 10.4.5. ASEAN
    • 10.4.5.1. By Application
  • 10.4.6. Rest of Asia Pacific

11. Company Profiles for Top 10 Players (Based on data availability in public domain and/or on paid databases)

• 11.1. Hamamatsu Photonics
  • 11.1.1. Overview
    • 11.1.1.1. Key Management
    • 11.1.1.2. Headquarters
    • 11.1.1.3. Offerings/Business Segments
  • 11.1.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.1.2.1. Employee Size
    • 11.1.2.2. Past and Current Revenue
    • 11.1.2.3. Geographical Share
    • 11.1.2.4. Business Segment Share
    • 11.1.2.5. Recent Developments
• 11.2. Olympus Corporation
  • 11.2.1. Overview
    • 11.2.1.1. Key Management
    • 11.2.1.2. Headquarters
    • 11.2.1.3. Offerings/Business Segments
  • 11.2.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.2.2.1. Employee Size
    • 11.2.2.2. Past and Current Revenue
    • 11.2.2.3. Geographical Share
    • 11.2.2.4. Business Segment Share
    • 11.2.2.5. Recent Developments
• 11.3. Affymetrix (thermo fisher scientific)
  • 11.3.1. Overview
    • 11.3.1.1. Key Management
    • 11.3.1.2. Headquarters
    • 11.3.1.3. Offerings/Business Segments
  • 11.3.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.3.2.1. Employee Size
    • 11.3.2.2. Past and Current Revenue
    • 11.3.2.3. Geographical Share
    • 11.3.2.4. Business Segment Share
    • 11.3.2.5. Recent Developments
• 11.4. Zeiss
  • 11.4.1. Overview
    • 11.4.1.1. Key Management
    • 11.4.1.2. Headquarters
    • 11.4.1.3. Offerings/Business Segments
  • 11.4.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.4.2.1. Employee Size
    • 11.4.2.2. Past and Current Revenue
    • 11.4.2.3. Geographical Share
    • 11.4.2.4. Business Segment Share
    • 11.4.2.5. Recent Developments
• 11.5. Zecotek Photonics Inc
  • 11.5.1. Overview
    • 11.5.1.1. Key Management
    • 11.5.1.2. Headquarters
    • 11.5.1.3. Offerings/Business Segments
  • 11.5.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.5.2.1. Employee Size
    • 11.5.2.2. Past and Current Revenue
    • 11.5.2.3. Geographical Share
    • 11.5.2.4. Business Segment Share
    • 11.5.2.5. Recent Developments
• 11.6. BD (Becton, Dickinson, and Company)
  • 11.6.1. Overview
    • 11.6.1.1. Key Management
    • 11.6.1.2. Headquarters
    • 11.6.1.3. Offerings/Business Segments
  • 11.6.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.6.2.1. Employee Size
    • 11.6.2.2. Past and Current Revenue
    • 11.6.2.3. Geographical Share
    • 11.6.2.4. Business Segment Share
    • 11.6.2.5. Recent Developments
• 11.7. PerkinElmer Inc.
  • 11.7.1. Overview
    • 11.7.1.1. Key Management
    • 11.7.1.2. Headquarters
    • 11.7.1.3. Offerings/Business Segments
  • 11.7.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.7.2.1. Employee Size
    • 11.7.2.2. Past and Current Revenue
    • 11.7.2.3. Geographical Share
    • 11.7.2.4. Business Segment Share
    • 11.7.2.5. Recent Developments
• 11.8. Lumenis Ltd.
  • 11.8.1. Overview
    • 11.8.1.1. Key Management
    • 11.8.1.2. Headquarters
    • 11.8.1.3. Offerings/Business Segments
  • 11.8.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.8.2.1. Employee Size
    • 11.8.2.2. Past and Current Revenue
    • 11.8.2.3. Geographical Share
    • 11.8.2.4. Business Segment Share
    • 11.8.2.5. Recent Developments
• 11.9. Bio-Rad Laboratories, Inc.
  • 11.9.1. Overview
    • 11.9.1.1. Key Management
    • 11.9.1.2. Headquarters
    • 11.9.1.3. Offerings/Business Segments
  • 11.9.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.9.2.1. Employee Size
    • 11.9.2.2. Past and Current Revenue
    • 11.9.2.3. Geographical Share
    • 11.9.2.4. Business Segment Share
    • 11.9.2.5. Recent Developments
• 11.10. Shimadzu
  • 11.10.1. Overview
    • 11.10.1.1. Key Management
    • 11.10.1.2. Headquarters
    • 11.10.1.3. Offerings/Business Segments
  • 11.10.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.10.2.1. Employee Size
    • 11.10.2.2. Past and Current Revenue
    • 11.10.2.3. Geographical Share
    • 11.10.2.4. Business Segment Share
    • 11.10.2.5. Recent Developments

12. Key Takeaways